LU92748I2 - Virus de la diarrhée virale bovine atténué 2 (bvdv-2) - Google Patents

Virus de la diarrhée virale bovine atténué 2 (bvdv-2) Download PDF

Info

Publication number
LU92748I2
LU92748I2 LU92748C LU92748C LU92748I2 LU 92748 I2 LU92748 I2 LU 92748I2 LU 92748 C LU92748 C LU 92748C LU 92748 C LU92748 C LU 92748C LU 92748 I2 LU92748 I2 LU 92748I2
Authority
LU
Luxembourg
Prior art keywords
bvdv
diarrhea virus
bovine viral
viral diarrhea
attenuated bovine
Prior art date
Application number
LU92748C
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Vetmdica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92748(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmdica Gmbh filed Critical Boehringer Ingelheim Vetmdica Gmbh
Publication of LU92748I2 publication Critical patent/LU92748I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU92748C 2004-05-19 2015-06-19 Virus de la diarrhée virale bovine atténué 2 (bvdv-2) LU92748I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025452A DE102004025452A1 (de) 2004-05-19 2004-05-19 Vakzine enthaltend BVDV

Publications (1)

Publication Number Publication Date
LU92748I2 true LU92748I2 (fr) 2015-11-02

Family

ID=34967522

Family Applications (3)

Application Number Title Priority Date Filing Date
LU92747C LU92747I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée bovine atténué 1 (bvdv-1)
LU92749C LU92749I2 (fr) 2004-05-19 2015-06-19 Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)
LU92748C LU92748I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée virale bovine atténué 2 (bvdv-2)

Family Applications Before (2)

Application Number Title Priority Date Filing Date
LU92747C LU92747I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée bovine atténué 1 (bvdv-1)
LU92749C LU92749I2 (fr) 2004-05-19 2015-06-19 Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)

Country Status (25)

Country Link
EP (1) EP1751276B9 (fr)
JP (2) JP5006782B2 (fr)
KR (1) KR100908798B1 (fr)
CN (2) CN103352030B (fr)
AR (2) AR049176A1 (fr)
AT (1) ATE420949T1 (fr)
AU (1) AU2005243488B2 (fr)
BR (1) BRPI0510396B1 (fr)
CA (1) CA2561719C (fr)
CY (4) CY1109036T1 (fr)
DE (2) DE102004025452A1 (fr)
DK (1) DK1751276T5 (fr)
ES (1) ES2321210T3 (fr)
HU (2) HUS1500033I1 (fr)
LU (3) LU92747I2 (fr)
ME (1) ME01119B (fr)
MX (1) MXPA06013298A (fr)
NL (3) NL300744I2 (fr)
NZ (1) NZ552088A (fr)
PL (1) PL1751276T3 (fr)
PT (1) PT1751276E (fr)
RS (1) RS50753B9 (fr)
SI (1) SI1751276T1 (fr)
UY (1) UY28905A1 (fr)
WO (1) WO2005111201A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
US8071108B2 (en) 2006-09-22 2011-12-06 Intervet International B.V. Pestivirus mutant for use in a vaccine
UY31437A1 (es) 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
SG10201506597RA (en) 2008-10-31 2015-10-29 Boehringer Ingelheim Vetmed Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
CA2811243C (fr) * 2010-09-21 2019-03-05 Intervet International B.V. Vaccin contre le bvdv
JP6589159B2 (ja) * 2014-04-01 2019-10-16 共立製薬株式会社 新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
US9993544B2 (en) * 2014-05-23 2018-06-12 Boehringer Ingelheim Vetmedica Gmbh Recombinant classical swine fever virus (CSFV) comprising substitution in the TAV epitope of the E2 protein
CN105779499B (zh) * 2016-03-23 2019-11-19 江苏科技大学 重组杆状病毒和其应用及构建该重组杆状病毒的载体
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
CN108707190B (zh) * 2018-04-18 2021-07-13 中国科学院武汉病毒研究所 猪瘟病毒ns5b蛋白保真度突变体及其应用
CN114853912B (zh) * 2022-05-24 2023-06-13 中国农业科学院兰州兽医研究所 一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用
CN115960847A (zh) * 2023-01-11 2023-04-14 青岛大学 小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (fr) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Virus de la diarrhée des bovins surs attenués pour utilisation chez des vaches gravides
CA2363493C (fr) * 2000-11-22 2006-06-06 Xuemei Cao Virus de la diarrhee virale bovine de formes attenuees
DE10143813A1 (de) * 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon

Also Published As

Publication number Publication date
CY2015023I2 (el) 2024-02-16
AU2005243488A1 (en) 2005-11-24
JP2012061001A (ja) 2012-03-29
DK1751276T3 (da) 2009-05-18
ATE420949T1 (de) 2009-01-15
ES2321210T3 (es) 2009-06-03
KR20070012862A (ko) 2007-01-29
NL300743I1 (fr) 2016-01-26
JP5562316B2 (ja) 2014-07-30
EP1751276A1 (fr) 2007-02-14
JP5006782B2 (ja) 2012-08-22
EP1751276B9 (fr) 2020-05-27
CN1989240A (zh) 2007-06-27
ME01119B (me) 2013-03-20
AU2005243488B2 (en) 2011-07-07
NL300745I2 (fr) 2016-01-26
CA2561719C (fr) 2015-01-27
NZ552088A (en) 2009-10-30
WO2005111201A1 (fr) 2005-11-24
NL300744I1 (fr) 2016-01-26
DK1751276T5 (da) 2020-07-20
PL1751276T3 (pl) 2009-06-30
NL300743I2 (fr) 2016-01-26
CN103352030B (zh) 2018-08-10
SI1751276T1 (sl) 2009-06-30
JP2007537740A (ja) 2007-12-27
KR100908798B1 (ko) 2009-07-22
CY2015021I1 (el) 2020-05-29
BRPI0510396B1 (pt) 2020-08-18
CN103352030A (zh) 2013-10-16
LU92747I2 (fr) 2015-11-02
CY1109036T1 (el) 2014-07-02
ES2321210T9 (es) 2020-11-04
AR049176A1 (es) 2006-07-05
CY2015022I1 (el) 2020-05-29
LU92749I2 (fr) 2015-11-02
RS50753B (sr) 2010-08-31
NL300745I1 (fr) 2016-01-26
UY28905A1 (es) 2005-12-30
PT1751276E (pt) 2009-02-24
AR104448A2 (es) 2017-07-19
HUS1500033I1 (hu) 2015-07-28
MXPA06013298A (es) 2007-05-07
CY2015022I2 (el) 2024-02-16
HUS1500031I1 (hu) 2019-11-28
NL300744I2 (fr) 2016-01-26
RS50753B9 (sr) 2020-08-31
BRPI0510396A (pt) 2007-11-13
DE602005012381D1 (de) 2009-03-05
DE102004025452A1 (de) 2006-01-19
EP1751276B1 (fr) 2009-01-14
CY2015023I1 (el) 2020-05-29
CY2015021I2 (el) 2023-11-15
CA2561719A1 (fr) 2005-11-24
CN1989240B (zh) 2013-07-31

Similar Documents

Publication Publication Date Title
LU92748I2 (fr) Virus de la diarrhée virale bovine atténué 2 (bvdv-2)
EP1948229A4 (fr) Vaccin combiné comprenant un virus atténué de la diarrhée virale bovine
NO2012018I1 (no) Canakinumab eller direkte ekvivalenter derav
MX245044B (es) Composiciones de filtro solar.
DK2206517T3 (da) Immunpotentierende sammensætninger omfattende af anti-PD-L1-antistoffer
GB0718984D0 (en) Structure of the hepatitis C virus NS5A protein
NO20044326D0 (no) Virale antigener
DK1252824T3 (da) Fremgangsmåde til forbedring af knoglemineralisering
AU2003254594A8 (en) Methods and compositions for detecting sars virus and other infectious agents
EP1723238A4 (fr) Virus oncolytiques modifies
DE60224595D1 (de) Fluoroelastomere
HK1121698A1 (en) Marked bovine viral diarrhea virus vaccines
DE60218117D1 (de) Vorverzerrungsschaltung
NO20030239D0 (no) Modifisert virus
NO20041984L (no) Stenter
DE60203066D1 (de) Weichmacherzusammensetzung
DK1749885T3 (da) Infektiøs og svækket kvægdiarévirus
ATE300179T1 (de) Biopestizid-zusammensetzungen
DE60216645D1 (de) Antiulcus pflanzenzusammensetzung(en)
DE50301116D1 (de) 9-alpha-substituierte estratriene als selektiv wirksame estrogene
EP1931382A4 (fr) Sequence proteique de l'enveloppe du virus de la dengue ancestral
ITTO20020744A1 (it) Composizione.
DE60226536D1 (de) Weichmacherzusammensetzung
AU2003272727A8 (en) Diagnosis of bovine viral diarrhea virus
EP1590357A4 (fr) Composes de carbohydrates bicycliques utilises dans le traitement d'infections provoquees par les flaviviridae, tels que les virus de l'hepatite c et la diarrhee virale bovine